The content on this site is intended for healthcare professionals only
Dr Sekeres speaks with ecancertv at ASH 2016 to discuss three presentations from a press conference he chaired at the conference.
For more on vadastuximab talirine, you can watch Dr Harry Erba speak with ecancer here.
From more on TKI cessation and dose reduction, you can watch interviews with Dr Francois-Xavier Mahon and Prof Mhairi Copland.
ecancer's filming at ASH 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Advancements in paediatric Acute lymphoblastic leukemia management
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Multiple myeloma in a resource constrained setting
Choosing Wisely in radiology Tanzania
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
